Baird Small/Mid Cap Growth Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Baird Small/Mid Cap Growth Fund Institutional Class BSGIX
- NAV / 1-Day Return $15.67 / +0.51 %
- Fund Size $62.6M
- Adjusted Expense Ratio 0.850%
- Net Expense Ratio 0.850%
- Fee Level: Distribution Average
- Share Class Type Institutional
- Morningstar Category Mid-Cap Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $10,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 58%
Morningstar’s Analysis BSGIX
Will BSGIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Government Obligs U | 4.45 | 3M | Cash and Equivalents |
Twilio Inc Class A | 4.02 | 3M | Technology |
Illumina Inc | 3.28 | 2M | Healthcare |
Victoria's Secret & Co | 3.26 | 2M | Consumer Cyclical |
Curtiss-Wright Corp | 2.64 | 2M | Industrials |
Glaukos Corp | 2.62 | 2M | Healthcare |
DexCom Inc | 2.56 | 2M | Healthcare |
Repligen Corp | 2.31 | 1M | Healthcare |
Littelfuse Inc | 2.29 | 1M | Technology |
Twist Bioscience Corp | 2.29 | 1M | Healthcare |